Drugs that suppress TSH or cause central hypothyroidism

被引:161
作者
Haugen, Bryan R. [1 ]
机构
[1] Univ Colorado Denver, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO 80045 USA
关键词
TSH; central hypothyroidism; medications; thyroid function; glucocorticoids; dopamine; somatostatin; rexinoids; THYROTROPIN-RELEASING-HORMONE; CLINICAL-RESEARCH CENTER; THYROID-FUNCTION; ORAL BEXAROTENE; SOMATOSTATIN RECEPTORS; LUTEINIZING-HORMONE; SECRETION; RAT; GLUCOCORTICOIDS; OCTREOTIDE;
D O I
10.1016/j.beem.2009.08.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Many different drugs affect thyroid function. Most of these drugs act at the level of the thyroid in patients with normal thyroid function. or at the level of thyroid hormone absorption or metabolism in patients requiring exogenous levothyroxine. A small subset of medications including glucocorticoids. dopamine agonists. somatostatin analogues and rexinoids affect thyroid function through suppression of TSH in the thyrotrope or hypothalamus Fortunately. most of these medications do not cause clinically evident central hypothyroidism A newer class Of nuclear hormone receptors agonists, called rexinoids, cause clinically significant central hypothyroidism in most patients and dopamine agonists may exacerbate 'hypothyroidism' in patients with non-thyroidal illness In this review, we explore mechanisms governing TSH suppression of these drugs and the clinical relevance of these effects. (C) 2009 Elsevier Ltd All rights reserved
引用
收藏
页码:793 / 800
页数:8
相关论文
共 46 条
  • [1] Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus
    Alkemade, A
    Unmehopa, UA
    Wiersinga, WM
    Swaab, DF
    Fliers, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) : 323 - 327
  • [2] THE ROLE OF GLUCOCORTICOIDS IN THE REGULATION OF THYROTROPIN
    BRABANT, A
    BRABANT, G
    SCHUERMEYER, T
    RANFT, U
    SCHMIDT, FW
    HESCH, RD
    VONZURMUHLEN, A
    [J]. ACTA ENDOCRINOLOGICA, 1989, 121 (01): : 95 - 100
  • [3] CAPPELLI C, 2009, DIABETES CARE 0605
  • [4] The rexinoid LG100754 is a novel RXR:PPARγ agonist and decreases glucose levels in vivo
    Cesario, RM
    Klausing, K
    Razzaghi, H
    Crombie, D
    Rungta, D
    Heyman, RA
    Lala, DS
    [J]. MOLECULAR ENDOCRINOLOGY, 2001, 15 (08) : 1360 - 1369
  • [5] EVIDENCE FOR THYROTROPIN-RELEASING-HORMONE AND GLUCOCORTICOID RECEPTOR-IMMUNOREACTIVE NEURONS IN VARIOUS PREOPTIC AND HYPOTHALAMIC NUCLEI OF THE MALE-RAT
    CINTRA, A
    FUXE, K
    WIKSTROM, AC
    VISSER, T
    GUSTAFSSON, JA
    [J]. BRAIN RESEARCH, 1990, 506 (01) : 139 - 144
  • [6] ACUTE AND CHRONIC EFFECTS OF OCTREOTIDE ON THYROID AXIS IN GROWTH HORMONE-SECRETING AND CLINICALLY NONFUNCTIONING PITUITARY-ADENOMAS
    COLAO, A
    MEROLA, B
    FERONE, D
    MARZULLO, P
    CERBONE, G
    LONGOBARDI, S
    DISOMMA, C
    LOMBARDI, G
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 133 (02) : 189 - 194
  • [7] Imatinib induces hypothyroidism in patients receiving levothyroxinc
    de Groot, JWB
    Zonnenberg, BA
    Plukker, JTM
    van Der Graaf, WTA
    Links, TP
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (04) : 433 - 438
  • [8] Duvic M, 2001, ARCH DERMATOL, V137, P581
  • [9] Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer
    Esteva, FJ
    Glaspy, J
    Baidas, S
    Laufman, L
    Hutchins, L
    Dickler, M
    Tripathy, D
    Cohen, R
    DeMichele, A
    Yocum, RC
    Osborne, CK
    Hayes, DF
    Hortobagyi, GN
    Winer, E
    Demetri, GD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) : 999 - 1006
  • [10] Dopamine infusion and anterior pituitary gland function in very low birth weight infants
    Filippi, L
    Pezzati, M
    Cecchi, A
    Serafini, L
    Poggi, C
    Dani, C
    Tronchin, M
    Seminara, S
    [J]. BIOLOGY OF THE NEONATE, 2006, 89 (04): : 274 - 280